chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PAIN; SWELLING; ITCHINESS; REDNESS; she has on her right arm what she describes as "mild symptoms": a rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (PAIN), SWELLING (SWELLING), PRURITUS (ITCHINESS), ERYTHEMA (REDNESS) and RASH (she has on her right arm what she describes as "mild symptoms": a rash) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030l20a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS (MULTIVIT [VITAMINS NOS]) and COLECALCIFEROL (VIT D [COLECALCIFEROL]) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN (PAIN), SWELLING (SWELLING), PRURITUS (ITCHINESS), ERYTHEMA (REDNESS) and RASH (she has on her right arm what she describes as "mild symptoms": a rash). At the time of the report, PAIN (PAIN), SWELLING (SWELLING), PRURITUS (ITCHINESS), ERYTHEMA (REDNESS) and RASH (she has on her right arm what she describes as "mild symptoms": a rash) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No corrective treatment was provided.
Received vaccination in left arm on April 14, 2009. On April 16th, noted tenderness on left hip which spread to groin. Pain continued and days later a rash developed. It was determined that I had developed shingles!! Still in pain.
lost weight; having all kinds of physical problems; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER COVID 19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL9262), via an unspecified route of administration on 01Mar2021 as 1ST DOSE, SINGLE DOSE and via an unspecified route of administration on an unspecified date in 2021 (Batch/Lot Number: not reported) as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient lost weight, body had changed and was having all kinds of physical problems ever since vaccine was received on 01Mar2021. The patient have these events from both the shots. Outcome of the events was unknown.  Information on the lot/batch, further information has been requested.
I have been having pain in my legs above and below my knees. I have pulsating pains under my left armpit and arm. Have been having headaches everyday that are worse first thing after waking up. Feels like I have a head cold (runny/stuffy nose, cough, sore throat) for the past 4 days that seems to be getting worse.
Itchy, bump, red, got bigger swollen, hard. Arm pain. Was given doxycycline.
This case was reported by a physician and described the occurrence of arm swelling in a five year old female pt who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. On 13Nov03, the pt received the fifth dose of Infanrix injected into the right arm. Two days post immunization, on 15Nov03, the pt experienced a red, hot and swollen arm and was seen at the physician's office. The event improved as of 21Nov03. The physician considered the event was probably related to vaccination with Infanrix.
3 immunizations given 1/4/11. On 1/6 developed diffuse urticarial appearing rash without symptoms. No target lesions or purpura. No joint swelling. Minimal response to 1.2 mg/kg dose of BENADRYL given multiple times. Resolved nearly completely by 1/9/11.
Intense burning in both eyes about an hour after the shot. After several hours, could no longer keep my eyes open the pain was so intense. Had to lie in bed until the next day. Pain was duller on day 2, has since resolved.
Headache, SkinRash, NauseaVomiting, Itchy face, red/dotted rash on face, tingling and numbness in chees (pins and needles) Narrative:
No adverse event; HCP confirms that 3 additional patients received expired dose on 18May2023 from the same lot number; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP confirms that 3 additional patients received expired dose on 18May2023 from the same lot number) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 069H22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 22-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-May-2023, received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 18-May-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP confirms that 3 additional patients received expired dose on 18May2023 from the same lot number). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP confirms that 3 additional patients received expired dose on 18May2023 from the same lot number) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (HCP confirms that 3 additional patients received expired dose on 18May2023 from the same lot number).    The vial size was 2.5 ml. The vial was initially stored in the refrigerator on 14Apr2023  The vial had not undergone any temperature excursions. HCP would like to know if the patients need to be revaccinated or if there are procedures to follow.   This case was linked to US-MODERNATX, INC.-MOD-2023-725148 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2023: Additional information received and included patient details (initial, age, DOB), Moderna Bivalent dose details updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-725148:Patient 1 out of 4 patients
11 Y/O pt, was administered Pfizer pediatric first dose.  Pt consent form was reviewed and all question were answered no. Pt received the vaccine without problem and then sat down in front of the pharmacy to wait for 15 minutes. After approximately 5 minutes pt wasn't feeling well and started crying and father called me, and the Pharmacist, over to the patient. Tech and myself ran to the patient.  The patient was complaining of not feeling well and her eyes felt weird. Upon examining the patient I found her eyes, lips, and face beginning to swell. At this point I called for a tech to bring the Epi-pen, call code white and call 911.  I assessed the patient breathing, airways, and circulation and they were good. Due to the facial swelling and distress from the patient I administered a dose of Epi-pen Jr into the patients left thigh.  Within minutes after administering the dose the pt said she was feeling better.  She continued saying she was having waves of nausea, some dizziness and felt like she was "in a dream." She did vomit 2 times after the dose was administered before EMS arrived.  We monitored the patient while waiting for EMS and she continued to progress with feeling better.  Once EMS arrived, I spoke with them about the what happen and administering the Epi-Pen.  They checked the pt's vitals and they were all good.  The pt felt well enough at this point to walk with EMS to the ambulance.   Pt returned to pharmacy later that day and had fully recovered.
I tested positive for COVID; I tested positive for COVID; This is a spontaneous report from a contactable consumer (patient). A 50-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EL3248) intramuscular, administered in Arm Right on 03Mar2021 12:45 (at the age of 50-years-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. No known allergies. No other vaccine in four weeks. No other medications in two weeks. No COVID prior to the vaccination. On 24Sep2021 18:30, the patient tested positive for COVID. The patient underwent lab tests and procedures which included SARS-CoV-2 test nasal swab on 24Sep2021 which was positive. No treatment was received for the adverse events. The outcome of the event was recovering.  Follow-up attempts are completed. No further information is expected.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient (pt) of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 2018, the pt was inoculated with the zoster vaccine live (ZOSTAVAX) vaccine at a health department as recommended for routine adult health maintenance and for the prevention of shingles (dose, route, and lot # not provided). Subsequently, pt. vaccination the pt, was treated by  healt care professional for shingles,( date unspecified date). As a direct and proximate result of zoster vaccine live (ZOSTAVAX)vaccine, and/or despite receiving zoster vaccine live (ZOSTAVAX) for long-term prevention of shingles, the pt suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the pt had suffered and would continue to suffer significant medical expenses, including but not limited to costs for hospitalization (unknown date), physician care, monitoring, treatment, medications and supplies and suffered ongoing injuries, pain and other damages. The outcome of the event was considered not recovered/not resolved.
A 40 year old man with no apparent risk factors for current disease presents with an anterior myocardial infarction. At acute in far related angioplasty is LAD is found to be completely included by fresh red clot that was removed using an instruction catheter. Imaging of the interior endothelial surface of the left anterior descending which was occluded by clot did not reveal any ruptured plaque or abnormality in the endothelium. He experience extensive anterior myocardial infarction and now has a left ventricular ejection fraction between 35 and 40%. This was an and usual presentation in a young man who appears to be fit with no family history of cardiac disease. A non-smoker. Normal lipid profile. The nature the invite itself was unusual in that no abnormality of the vessel that was occluded by fresh thrombus could be detected
Pt called today with c/o headache, generalized achiness and fatigue, decreased appetite, stomach aches, nausea and diarrhea.
After my initial shot, I experienced the usual arm tenderness and a slight headache for 2 days. Then, a week later on 2/3/21, I noticed my left arm was once again very sore and painful to the touch and movement. On 2/4/21, I started massaging the injection site (on my left arm) frequently during the day which made the site extremely itchy afterwards. I have continued to massage the site daily and the pain has decreased daily. Today I still have a slight tenderness and I will continue to massage until hopefully it is pain free.
patient felt lightheaded and nauseated. Had a little emesis and then felt better.  Mild vagal response resolved
No additional adverse events reported; The patient was administered with improperly stored vaccine; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. Information about the patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapies was not reported.   On 27-DEC-2021, the patient was vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin (rHA)) (M-M-R II) (lot# T033815, expiration date 05-OCT-2022; strength, dose and route were not reported) for prophylaxis (product storage error).  The administered vaccine experienced a temperature excursion in 49.6 Fahrenheit degrees (F) for 35 hours 9 minutes. The previous temperature excursion included 32.9 F for 53 hours 16 minutes, 49.1 F for 5 hours 9 minutes, and 56.3 F for 14 hours 7 minutes. No additional adverse events reported.   This is one of multiple cases received from the same reporter.; Sender's Comments:  US-009507513-2202USA003592: US-009507513-2203USA003312: US-009507513-2203USA003313: US-009507513-2203USA003314: US-009507513-2203USA003315: US-009507513-2203USA003316: US-009507513-2203USA003317: US-009507513-2203USA003318: US-009507513-2203USA003319: US-009507513-2203USA003320: US-009507513-2203USA003335: US-009507513-2203USA003322: US-009507513-2203USA003323: US-009507513-2203USA003324: US-009507513-2203USA003325: US-009507513-2203USA003326: US-009507513-2203USA003327: US-009507513-2203USA003328: US-009507513-2203USA003329: US-009507513-2203USA003330: US-009507513-2203USA003331: US-009507513-2203USA003332: US-009507513-2203USA003333: US-009507513-2203USA003334: US-009507513-2203USA003311: US-009507513-2203USA003321:
Felt sick; Headache; Felt achy; Throat glands were swollen; Horrible sore throat; Voice is raspy; Itching everywhere; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt sick), HEADACHE (Headache), PAIN (Felt achy), PHARYNGEAL SWELLING (Throat glands were swollen) and OROPHARYNGEAL PAIN (Horrible sore throat) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history was provided.).    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced MALAISE (Felt sick), HEADACHE (Headache), PAIN (Felt achy), PHARYNGEAL SWELLING (Throat glands were swollen), OROPHARYNGEAL PAIN (Horrible sore throat), VOCAL CORD THICKENING (Voice is raspy) and PRURITUS (Itching everywhere). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN (ADVIL 12 HOUR) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, MALAISE (Felt sick), HEADACHE (Headache), PAIN (Felt achy), PHARYNGEAL SWELLING (Throat glands were swollen), OROPHARYNGEAL PAIN (Horrible sore throat), VOCAL CORD THICKENING (Voice is raspy) and PRURITUS (Itching everywhere) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Blood clots in left leg diagnosed in Hospital, ,  emergency room 02/08/2021, about 5 hours after first vaccine.  Treated with eliquis.  History of prior embolus and blood clots.  Referred to primary physician who referred me to a vascular surgeon and a hematologist.  For about 3 days extremely tired and slept quite a bit.  I already have rotator cuff injury of arm where I got shot so pain was not able to be separated from rotator cuff pain.  No temperature, rash, redness or swelling of injection site.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warmness at the injection site), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warmness at the injection site), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). At the time of the report, VACCINATION SITE WARMTH (Warmness at the injection site), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
This spontaneous report was received from a registered nurse and refers to a 37 year old male patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 14-DEC-2016, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(manufacturer unknown), lot # M015735 with expiration date of 30-MAR-2018 (dose, route and frequency were not reported) for prophylaxis. It was stated that the vaccine underwent a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 78 days. It was reported that there was no need to repeat vaccine. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1705USA014053.
Patient was present at our Moderna vaccine clinic at his Assisted Living Residence where he resides. He did not tell us that he had obtained a Pfizer vaccine previously. We gave him Moderna vaccine on 2/2/21. We received a call from staff at the community days later who reported that the patient had received Pfizer dose #1 on 1/18/21. No side effects or unusual events have been reported at this time.
Headache beginning shorty after vaccination persisting rest of day. Intermittent headaches of greater severity on right/top right of head starting 42 hours after injection. Currently 75 hours post-injection and intermittent headaches persist. Moderate light/sound sensitivity.
This spontaneous report as received from a medical assistant to a patient of unknown age and gender. On 18-AUG-2014 the patient was vaccinated with ZOSTAVAX lot # J003798, expiration date: 28-JUN-2014 (dose and route not reported) that expired on 28-JUN-2014. No concomitant medications were reported. No adverse effect was reported. Additional information has been requested.
I had a sore throat with chills. I also had body aches as well as congestion and headache. I treated it with liquids and the diabetic Tussin. I completed a home COVID-19, and it was Positive.  I contacted my doctor to get Paxlovid but was not given a prescription. I used Zinc, Vitamin D & C as well as probiotics to treat. I still have a cough and still get short of breath when speaking to much, but I began to feel better on Wednesday. On Tuesday I went to urgent care because my throat was still sore. I was tested for strep and it was negative. I also developed swollen lymph nodes under my left arm which lasted about a week. I did not see a doctor for this.
CRAMPING, TIGHTNESS AROUND WAIST, VERY UNCOMFORTABLE FEELING IN LOWER STOMACH, SWEATING,LIGHT HEADED
2nd shot was 5/28/21 Lot # EW.  Patient presented to ED on 6/7 with a report of five separate times over the past 2 weeks of 5 minutes painless vision loss in his left eye. Last night he had painless vision loss in his right eye, which has not returned. CTA reveals L carotid stenosis and possible R carotid dissection. Eye exam consistent with R eye central retina artery occlusion.
6 year old female with meningoencephalitis (cause unknown) who has been recovering over last 2.5 months. She received the vaccine and developed more encephalopathic symptoms about 8 hours after receiving the vaccine. She is 11 days out from vaccine and still has slurred speech, word-finding difficulty, gait difficulties, etc. Discharge Summary received on 12/07/2004 states abdominal pain, leg pain, fever, headache, stiff neck, unresponsive, irritable, sleepy, decreased stregnth, decreased po intake, urinary retention, and bladder spasm. Medical Records received on 12/07/2004 states vomiting. Follow up 03/04/05: Patient has almost completely recovered. She still has some fine motor and cognative deficits. We did give her a prolonged course of steroids after her MRI was consistent with "Acute Demyelinating Encephalomyelitis". She has improved neurologic function. Per annual follow report 1/26/2006 She still has subtel cognitive/processing problems, she has balance issues.
Mother called the day after vaccines administered to report that patient had temp of 103 degrees F. Mother advised to give Tylenol or Ibuprofen and bring patient in for evaluation. No other treatment needed.
This spontaneous report as received from a registered nurse refers to an unspecified number of unspecified patients of unknown age. On an unspecified dates, doses of improperly stored (Oka/Merck) VARIVAX (dose/frequency and lot# were unknown) might had been administered to patients for prophylaxis; this was unable to be confirmed with nurse. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Chills, fever 100.9, headache, fatigue. Symptoms started approximately 10 hours After a vaccination. Fever lasted 18 hours, headache 48 hours, fatigue five days. I did want to mention that I tested positive for Covid on December 9. I was completely symptom-free before the vaccination.
I started feeling nausea a few weeks prior to the event and took ZOFRAN, on 10FEB2023 I started a double dose of lansoprazole my symptoms were lack of appetite stomach discomfort complete fullness feeling I was not able to eat and trying to keep fluids and basic nutrition. I tried to get an appointment with my Gastro 10March2023 was the first available. 15FEB2023 and 16FEB2023 I was feeling lightheaded and winded I couldn't tell if it was reflux or whatever 13FEB2023 and on 17FEB2023 I passed out my husband caught me he called EMS they came and I came to right away I was taken to the ER concerned of heart attack or anxiety. By 17FEB2023 I was released on Saturday around five PM. I was told the conditions were a perfect storm and they described vasovagal episode, stress and anxiety. I was told to follow up with PCP. On 21FEB2023 I saw my Primary care and she got to the Gastro and they scheduled an Endoscopy on 02MAR2023. I have gastritis and stress.
Information has been received from a 60 year old registered nurse with no known allergies who on an unspecified date was vaccinated intramuscularly, instead of subcutaneously, with a dose of ZOSTAVAX. The patient was not experiencing any known symptoms. There was no further information provided. There was no product quality complaint involved. Follow up information from a registered nurse about the patient states that the patient developed an arm that was sore for a day or two after receiving the vaccination. The patient has recovered from the sore arm. Additional information is not expected. This is one of several reports from the same source.